Verici DX (VRCI) RNS Announcements

Add to Alert list
Date Time Source Announcement
31 Jul 2025 05:28 PM
RNS
Holding(s) in Company
31 Jul 2025 03:24 PM
RNS
Holding(s) in Company
31 Jul 2025 07:00 AM
RNS
Tutivia™ abstracts for World Transplant Congress
30 Jul 2025 02:32 PM
RNS
Holding(s) in Company
30 Jul 2025 02:26 PM
RNS
Holding(s) in Company
30 Jul 2025 07:00 AM
RNS
Result of Annual General Meeting
29 Jul 2025 07:00 AM
RNS
Result of WRAP Retail Offer
28 Jul 2025 05:19 PM
RNS
Holding(s) in Company
28 Jul 2025 04:55 PM
RNS
Holding(s) in Company
28 Jul 2025 10:23 AM
RNS
Holding(s) in Company
25 Jul 2025 05:22 PM
RNS
Holding(s) in Company
25 Jul 2025 01:05 PM
RNS
Holding(s) in Company
25 Jul 2025 01:04 PM
RNS
Holding(s) in Company
24 Jul 2025 02:34 PM
RNS
Holding(s) in Company
22 Jul 2025 07:00 AM
RNS
WRAP Retail Offer for up to £500,000
21 Jul 2025 03:43 PM
RNS
Result of Placing & Subscription
21 Jul 2025 07:00 AM
RNS
Proposed Fundraising
30 Jun 2025 07:00 AM
RNS
Final Results
11 Jun 2025 07:00 AM
RNS
Update on funding to accelerate commercial growth
27 May 2025 02:42 PM
RNS
Result of General Meeting
09 May 2025 04:38 PM
RNS
Publication of Circular
06 May 2025 12:16 PM
RNS
Holding(s) in Company
10 Apr 2025 08:06 AM
RNS
Verici Receives Medicare Coverage for Tutivia
07 Apr 2025 07:00 AM
RNS
Significant Test Growth with Medicare Pending
14 Jan 2025 11:01 AM
RNS
Holding(s) in Company
11 Oct 2024 07:00 AM
RNS
Update on Local Coverage Determination and Trading
31 Jul 2024 07:00 AM
RNS
Launch of PTRA Assay using Verici Dx's technology
15 Jul 2024 07:00 AM
RNS
Half-year Report
11 Jul 2024 02:00 PM
RNS
Notice of Results and Business Update
01 Jul 2024 07:00 AM
RNS
Significant milestone re Thermo Fisher agreement
25 Jun 2024 01:27 PM
RNS
Result of AGM
18 Jun 2024 07:00 AM
RNS
Transfer of urine samples to Thermo Fisher
31 May 2024 01:57 PM
RNS
Notice of AGM and posting of Annual Report
31 May 2024 10:00 AM
RNS
Launch of patient-focused educational tool
30 May 2024 07:00 AM
RNS
2023 Annual Results
24 May 2024 07:00 AM
RNS
New data to be presented at ATC
27 Feb 2024 04:08 PM
RNS
Holding(s) in Company
22 Feb 2024 07:00 AM
RNS
Holding(s) in Company
21 Feb 2024 04:53 PM
RNS
Holding(s) in Company
21 Feb 2024 07:00 AM
RNS
Holding(s) in Company
19 Feb 2024 12:35 PM
RNS
Result of General Meeting
14 Feb 2024 07:00 AM
RNS
Result of Retail Offer
31 Jan 2024 07:00 AM
RNS
Verici Dx announces new research initiative
26 Jan 2024 12:32 PM
RNS
Publication of Circular
25 Jan 2024 11:00 AM
RNS
Launch of Retail Offer
24 Jan 2024 06:11 PM
RNS
Result of Placing
24 Jan 2024 10:39 AM
RNS
Close of Accelerated Bookbuild
24 Jan 2024 07:00 AM
RNS
Proposed Fundraising
08 Jan 2024 07:00 AM
RNS
CAP accreditation
08 Jan 2024 07:00 AM
RNS
Medicare National Payment Rate Confirmation

Verici Dx is an immuno-diagnostics company that produces advanced clinical tests and organ transplant platforms for kidney transplant patients.

Verici Dx share price is listed in London under the ticker VRCI.

UK 100

Latest directors dealings